Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 308-662-5 | CAS number: 98171-53-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test material is considered to be non-mutagenic in vitro micronucleus test, when tested up to precipitating concentrations.
The test substance is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay.
The test item is considered to be non-mutagenic in the HPRT assay.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In vitro micronucleus test
The test material, suspended in culture medium, was assessed for its potential to induce micronuclei in human lymphocytesin vitroin two independent experiments.
In each experimental group two parallel cultures were analyzed. Per culture at least 1000 binucleated cells were evaluated for cytogenetic damage.
The highest applied concentration in this study (2105 µg/mL of the test item) was chosen with regard to the purity (95%) of the test item and with respect to the current OECD Guideline 487.
Dose selection of the cytogenetic experiment was performed considering the toxicity data and the occurrence of test item precipitation in accordance with OECD Guideline 487.
In the absence and presence of S9 mix, no cytotoxicity was observed up to the highest evaluated concentration, which showed precipitation.
In the absence and presence of S9 mix, no relevant increase in the number of micronucleated cells was observed after treatment with the test item. In Experiment I in the absence of S9 mix, however, two values (1.45 and 1.13%) after treatment with 24.4 and 42.8 µg/mL, respectively, slightly exceeded the historical control data range (0.08 – 1.12% micronucleated cells). In the presence of S9 mix one value (1.35%), after treatment with 74.8 µg/mL, slightly exceeded the historical control data range (0.16 – 1.08% micronucleated cells). None of these values showed a statistical significance.
Appropriate mutagens were used as positive controls. They induced statistically significant increases in cells with micronuclei.
In conclusion, it can be stated that under the experimental conditions reported, the test item did not induce micronuclei as determined by the in vitro micronucleus test in humanlymphocytes.
Therefore, the test material is considered to be non-mutagenic in this in vitro micronucleus test, when tested up to precipitating concentrations.
Salmonella typhimurium/Escherichia coli reverse mutation assay
The test substance was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay.
STRAINS: TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA
DOSE RANGE: 1 μg - 5300 μg/plate (SPT), 1 μg - 5300 μg/plate (PIT)
TEST CONDITIONS: Standard plate test (SPT) and preincubation test (PIT) both with and without metabolic activation (liver S9 mix from induced rats).
SOLUBILITY: Precipitation of the test substance was found in the standard plate from about 2650 μg/plate onward with and without S9 mix.
ACCEPTANCE CRITERIA: The experiment was considered valid since the acceptance criteria were met. The results of the negative as well as the positive controls performed in parallel corroborated the validity of this study, since the values fulfilled the acceptance criteria. In this study with and without S9 mix, the number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain. In addition, the positive control substances with and without S9 mix induced a significant increase in the number of revertant colonies within the range of the historical positive control data.
TOXICITY: A bacteriotoxic effect was observed depending on the strain and test conditions from about 100 μg/plate onward.
MUTAGENICITY: A relevant increase in the number of his+ or trp+ revertants (factor ≥ 2: TA 100, TA 98 and E.coli WP2 uvrA or factor ≥ 3: TA 1535 and TA 1537) was not observed in the standard plate test or in the preincubation test without S9 mix or after the addition of a metabolizing system.
CONCLUSION: Under the experimental conditions of this study, the test substance is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
HPRT assay:
The study was performed to investigate the potential of the test material to induce gene mutations at the HPRT locus in V79 cells of the Chinese hamster.
The assay was performed in two independent experiments, using two parallel cultures each.
The first main experiment was performed with a treatment period of 4 hours with and without microsomal activation. The second main experiment was performed with a 24 hours treatment period without microsomal activation and a 4 hours treatment period with microsomal activation.
The maximum test item concentration of the pre-experiment (2105.0 µg/mL) was chosen with respect to the current OECD guideline 476 regarding the water content of the test item.
The test item was suspended in culture medium.
The evaluated experimental points and the results are summarised inTable1.
The highest evaluated concentration in experiment I with and without metabolic activation and in experiment II with metabolic activation was limited by precipitation. The highest evaluated concentration in experiment II without metabolic activation was limited by cytotoxicity.
Cytotoxic effect indicated by an adjusted cloning efficiency I below 50% in both cultures was observed in experiment I at 93.75 µg/mL without metabolic activation, and in experiment II at 125.0 µg/mL and above without metabolic activation.
In experiment I the 95% confidence interval was exceeded at 93.75 µg/mL in culture without metabolic activation, and at 15.63 µg/mL in both cultures with metabolic activation. In experiment II without metabolic activation the 95% confidence interval was exceeded at 31.25 µg/mL in culture I, at 62.5 µg/mL in both cultures, at 150.0 µg/mL in culture I, and at 187.5 µg/mL in culture II. In experiment II with metabolic activation the 95% confidence interval was exceeded at 125.0 µg/mL in culture II. These isolated increases were judged as irrelevant as they were not reproduced and there was no dose dependent increase as indicated by a lacking statistical significance.
A t-test evaluating the data of both parallel cultures at these test points showed a significant response in experiment I at 93.75 µg/mL in the absence of metabolic activation. However, since this was the second concentration were precipitation was observed, this concentration will not be taken into the consideration of the judgement of the outcome of this study. In the presence of metabolic activation in experiment I the t-test showed a significant response at 15.63 µg/mL. However, this was the lowest concentration and there was no significant t-test at any other, even higher concentration. In experiment II with metabolic activation the t-test showed a significant response at 125.0 µg/mL. However no statistical significance was observed in the linear regression analysis. Furthermore the relative adjusted cloningefficiencyI at this concentration was below 10%. Therefore this concentration will not be taken into the consideration of the judgement of the outcome of this study.
A linear regression analysis (least squares) was performed to assess a possible dose dependent increase of mutant frequencies. A significant dose dependent trend of the mutation frequency indicated by a probability value of <0.05 was determined in the first culture of experiment I without metabolic activation. As the trend was not reproduced in the parallel culture it is consequently judged as irrelevant fluctuation. All other experimental parts showed no significant dose dependent trend of the mutation frequency.
All in all, no substantial and reproducible dose dependent increase of the mutation frequency was observed in the main experiments.
Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, the test material is considered to be non-mutagenic in this HPRT assay.
Justification for classification or non-classification
The available studies are considered reliable and suitable for classification purposes under (EC) No. 1272/2008.
As a result the substance is not considered to be classified for genotoxicity under (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.